Tetragon Partners GP Ltd
CIK
1515070
Location
GRAND CAYMAN, E9
Portfolio Value
Small
$635,255,072
Diversification
Highly concentrated
Reports for
Tetragon Partners L.P.
Tetragon Partners UK LLP
Tetragon Partners US LP
Filing Date
Global Rank
#3,318
/ 8,795
▼ 39
· as of Jun 2026
Top Industry
Software - Infrastructure
53.0%
3Y Alpha vs SPY
-10.2%
Period ended 3 months ago
Filed Aug 13, 2026 · 54d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
36 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
53.0%
−1.7 pts
Top 5
65.1%
−7.3 pts
Top 10
74.2%
−8.8 pts
HHI
2,898
Highly concentrated−225
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 61.1% | $387,938,145 |
| Healthcare | 32.5% | $206,616,099 |
| Energy | 5.4% | $34,035,829 |
| Communication Services | 1.0% | $6,664,999 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PATH | UiPath, Inc. | +5,742,372 | 30,950,000 | $336,426,499 | |
| SLN | Silence Therapeutics plc | +434,095 | 1,064,256 | $11,685,530 | |
| RLAY | Relay Therapeutics, Inc. | +388,768 | 570,311 | $10,670,518 | |
| KPTI | Karyopharm Therapeutics Inc. | +147,316 | 250,300 | $2,445,431 | |
| DYN | Dyne Therapeutics, Inc. | +98,525 | 356,657 | $7,921,351 | |
| AGIO | Agios Pharmaceuticals, Inc. | +90,740 | 255,579 | $9,484,536 | |
| DFTX | Definium Therapeutics, Inc. | +86,996 | 286,990 | $13,500,009 | |
| HRMY | Harmony Biosciences Holdings, Inc. | +81,696 | 201,036 | $7,319,720 | |
| PHVS | Pharvaris N.V. | +74,016 | 295,627 | $10,222,781 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +60,527 | 100,000 | $3,339,000 | |
| MBX | MBX Biosciences, Inc. | +58,063 | 203,543 | $11,235,573 | |
| IONS | Ionis Pharmaceuticals Inc | +55,409 | 97,173 | $7,704,847 | |
| IMVT | Immunovant, Inc. | +37,427 | 255,934 | $9,861,137 | |
| ALKS | Alkermes plc. | +30,188 | 189,979 | $9,954,899 | |
| ACAD | Acadia Pharmaceuticals Inc | +23,255 | 167,875 | $4,247,237 | |
| TECX | Tectonic Therapeutic, Inc. | +8,928 | 46,516 | $1,599,220 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +3,286 | 130,484 | $10,635,750 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WBD | Warner Bros. Discovery, Inc. | −673,725 | 250,000 | $6,664,999 | |
| ANNX | Annexon, Inc. | −50,000 | 1,242,455 | $7,094,418 | |
| CLDX | Celldex Therapeutics, Inc. | −21,875 | 290,441 | $10,807,309 | |
| AXSM | Axsome Therapeutics, Inc. | −20,059 | 35,000 | $8,566,950 | |
| NKTR | Nektar Therapeutics | −16,041 | 86,996 | $6,073,190 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −11,451 | 306,426 | $5,503,410 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKT | Alkami Technology, Inc. | 600,284 | $10,877,146 | |
| CELC | Celcuity Inc. | 64,110 | $6,707,188 | |
| CUE | Cue Biopharma, Inc. | 93,819 | $2,960,927 | |
| ACRS | Aclaris Therapeutics, Inc. | 400,000 | $2,116,000 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 56,052 | $1,356,458 | |
| TENX | Tenax Therapeutics, Inc. | 75,100 | $1,092,705 | |
| No positions match the current search. | ||||
36 tracked positions ·
$635,255,072 total
· filing declares
43 positions · $635,063,221
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PATH |
UiPath, Inc.
Technology
|
Added | 30,950,000 | $336,426,499 | 52.96% | |
| KGEI |
Kolibri Global Energy Inc.
Energy
|
Held | 6,834,504 | $34,035,829 | 5.36% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Held | 9,500,000 | $15,200,000 | 2.39% | |
| LYFT |
Lyft, Inc.
Technology
|
Held | 1,000,000 | $14,610,000 | 2.30% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 286,990 | $13,500,009 | 2.13% | |
| WK |
Workiva Inc
Technology
|
Held | 250,000 | $12,127,500 | 1.91% | |
| SLN |
Silence Therapeutics plc
CALL
+ SHARES
Healthcare
|
Added | 1,064,256 | $11,685,530 | 1.84% | |
| CXM |
Sprinklr, Inc.
Technology
|
Held | 2,200,000 | $11,352,000 | 1.79% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 203,543 | $11,235,573 | 1.77% | |
| ALKT |
Alkami Technology, Inc.
Technology
|
NEW | 600,284 | $10,877,146 | 1.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 290,441 | $10,807,309 | 1.70% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 570,311 | $10,670,518 | 1.68% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 130,484 | $10,635,750 | 1.67% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 295,627 | $10,222,781 | 1.61% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 189,979 | $9,954,899 | 1.57% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 255,934 | $9,861,137 | 1.55% | |
| AGIO |
Agios Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Added | 255,579 | $9,484,536 | 1.49% | |
| AXSM |
Axsome Therapeutics, Inc.
CALL
Healthcare
|
Reduced | 35,000 | $8,566,950 | 1.35% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 356,657 | $7,921,351 | 1.25% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 97,173 | $7,704,847 | 1.21% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Added | 201,036 | $7,319,720 | 1.15% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Held | 19,668 | $7,310,005 | 1.15% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Reduced | 1,242,455 | $7,094,418 | 1.12% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 64,110 | $6,707,188 | 1.06% | |
| WBD |
Warner Bros. Discovery, Inc.
Communication Services
|
Reduced | 250,000 | $6,664,999 | 1.05% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 86,996 | $6,073,190 | 0.96% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 306,426 | $5,503,410 | 0.87% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 167,875 | $4,247,237 | 0.67% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
CALL
Healthcare
|
Added | 100,000 | $3,339,000 | 0.53% | |
| CUE |
Cue Biopharma, Inc.
Healthcare
|
NEW | 93,819 | $2,960,927 | 0.47% | |
| SNOW |
Snowflake Inc.
Technology
|
Held | 10,000 | $2,545,000 | 0.40% | |
| KPTI |
Karyopharm Therapeutics Inc.
CALL
Healthcare
|
Added | 250,300 | $2,445,431 | 0.38% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
NEW | 400,000 | $2,116,000 | 0.33% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Added | 46,516 | $1,599,220 | 0.25% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 56,052 | $1,356,458 | 0.21% | |
| TENX |
Tenax Therapeutics, Inc.
CALL
Healthcare
|
NEW | 75,100 | $1,092,705 | 0.17% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.